Opioids Don't Top Non-Opioids for Pain-Related Function

Share this content:
Opioids Don't Top Non-Opioids for Pain-Related Function
Opioids Don't Top Non-Opioids for Pain-Related Function

TUESDAY, March 6, 2018 (HealthDay News) -- Opioid treatment is not superior to non-opioid treatment for improving pain-related function over 12 months, according to a study published in the March 6 issue of the Journal of the American Medical Association.

Erin E. Krebs, M.D., M.P.H., from the Minneapolis Veterans Affairs Health Care System, and colleagues compared opioid versus non-opioid medications over 12 months in a randomized trial. Two hundred forty patients with moderate-to-severe chronic back pain or hip or knee osteoarthritis pain despite analgesic use were randomized; 234 completed the trial.

The researchers observed no significant difference between the groups in pain-related function over 12 months (overall P = 0.58); the mean 12-month Brief Pain Inventory (BPI) interference was 3.4 and 3.3 for the opioid and non-opioid groups, respectively (difference, 0.1; 95 percent confidence interval, −0.5 to 0.7). Over 12 months, pain intensity was significantly better in the non-opioid group (overall P = 0.03); the mean BPI severity was 4.0 and 3.5 for the opioid and non-opioid groups, respectively (difference, 0.5; 95 percent confidence interval, 0.0 to 1.0). Over 12 months, adverse medication-related symptoms were significantly more common in the opioid group (overall P = 0.03).

"Results do not support initiation of opioid therapy for moderate-to-severe chronic back pain or hip or knee osteoarthritis pain," the authors write.

One author disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Ground Beef Recalled After E. Coli Outbreak

Ground Beef Recalled After <i>E. Coli</i> Outbreak

Beef was produced and packaged at Cargill Meat Solutions in Fort Morgan, Colo.

Prevalence of Alzheimer's, Related Dementia Set to Double

Prevalence of Alzheimer's, Related Dementia Set to Double

Alzheimer's disease and related dementias burden is expected to increase to 3.3 percent in 2060

Long-Term Outcomes of Breast Implants Explored

Long-Term Outcomes of Breast Implants Explored

Higher rates of Sjogren syndrome, scleroderma, RA, stillbirth, melanoma for silicone implants

is free, fast, and customized just for you!




Already a member?

Sign In Now »